1. METHODOLOGICAL APPROACHES TO THE DETERMINATION OF CHEMORESISTANCE OF HUMAN CANCER CELLS TO ANTI-CANCER DRUGS
   K. I. Kirsanov et al, 2020, Siberian journal of oncology CrossRef
2. In ovo model in cancer research and tumor immunology
   Lea Miebach et al, 2022, Frontiers in Immunology CrossRef
3. Impact of RARα and miR-138 on retinoblastoma etoposide resistance
   Maike Busch et al, 2021, Tumor Biology CrossRef
4. Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma
   Natalia Miroschnikov et al, 2023, Journal of Oncology CrossRef
5. New retinoblastoma (RB) drug delivery approaches: anti‐tumor effect of atrial natriuretic peptide (ANP)‐conjugated hyaluronic‐acid‐coated gold nanoparticles for intraocular treatment of chemoresistant RB
   André Haase et al, 2024, Molecular Oncology CrossRef
6. Implementation of the Chick Chorioallantoic Membrane (CAM) Model in Radiation Biology and Experimental Radiation Oncology Research
   null Dünker et al, 2019, Cancers CrossRef
7. Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma
   Vinodh Kakkassery et al, 2022, International Journal of Molecular Sciences CrossRef
8. Progress in the Treatment of Retinoblastoma
   凡 杨, 2019, World Journal of Cancer Research CrossRef